ZELIRA THERAPEUTICS LIMITED - Announcements

7.32%

38.0¢

Market Cap $4.877M

Healthcare Biotechnology

Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company... Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company is engaged in the research, development and commercialization of clinically validated cannabinoid-based medicines. It owns a portfolio of products and a pipeline of candidates undergoing clinical development positioned to enter global markets. It is focused on developing and clinically validating branded cannabinoid-based medicines in its prescription (Rx) business for the treatment of a variety of medical conditions, including insomnia, autism and chronic non-cancer pain, as well as offering over the counter (OTC) products. It has two medications: HOPE and ZENIVOL. ZENIVOL is a cannabinoid-based medicine for the treatment of chronic insomnia. The Company in partnership with SprinJeneCBD, introduced a full line of oral care products, including SprinJeneCBD toothpaste product, which is a hemp-derived, oral care products containing cannabinoids, blackseed oil and zinc utilizing patented technology.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) to benefit as Denmark commits to cannabis pilot program.

Announcements

Filter Results

All Price Sensitive Only

ZLD	Preliminary Final Report	PRICE SENSITIVE	29/08/25	331.11KB	Share
ZLD	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/07/25	1.41MB	Share
ZLD	Zelira Therapeutics Secures R&D Loan Facility	PRICE SENSITIVE	24/07/25	1.65MB	Share
ZLD	Publication of ZLT-L-007 IRB Approved Observational Study	PRICE SENSITIVE	22/05/25	2.41MB	Share
ZLD	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/25	2.11MB	Share
ZLD	Full Conversion of $USD3.25M Convertible Notes in HOPE SPV		28/04/25	1.66MB	Share
ZLD	Investor Presentation		03/04/25	13.48MB	Share
ZLD	Application for quotation of securities - ZLD		01/04/25	16.09KB	Share
ZLD	Cleansing Prospectus		31/03/25	434.49KB	Share
ZLD	Proposed issue of securities - ZLD		31/03/25	15.34KB	Share
ZLD	Zelira secures $1 Million At-the-Market Funding Facility	PRICE SENSITIVE	31/03/25	1.94MB	Share
ZLD	Appendix 4D & FY25 Interim Financial Report	PRICE SENSITIVE	26/02/25	3.46MB	Share
ZLD	Zelira receives $1,153,000 R&D Tax Incentive Scheme Refund	PRICE SENSITIVE	18/02/25	1.36MB	Share
ZLD	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/01/25	1.83MB	Share
ZLD	Zeliras HOPE SPV Secures US$681,000 Fourth Funding Tranche	PRICE SENSITIVE	28/01/25	1.54MB	Share
ZLD	Change of Director's Interest Notice x 2		20/01/25	227.55KB	Share
ZLD	Notification of cessation of securities - ZLD		17/01/25	12.76KB	Share
ZLD	Change of Director's Interest Notice		19/12/24	208.86KB	Share
ZLD	Notification regarding unquoted securities - ZLD		18/12/24	18.97KB	Share
ZLD	Zelira to present at Automic Invest 2024 conference		20/11/24	267.35KB	Share
ZLD	Proposed issue of securities - ZLD		14/11/24	18.41KB	Share
ZLD	Results of Meeting		14/11/24	265.07KB	Share
ZLD	2024 Annual General Meeting Presentation		14/11/24	5.23MB	Share
ZLD	Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/10/24	205.83KB	Share
ZLD	September 2024 Quarterly Activities Report	PRICE SENSITIVE	29/10/24	1.65MB	Share
ZLD	Letter to Shareholders		11/10/24	222.62KB	Share
ZLD	Notice of Annual General Meeting/Proxy Form		11/10/24	461.61KB	Share
ZLD	Investor Webinar - HOPE FDA Program Update		20/09/24	1.29MB	Share
ZLD	Notice of Investor Webinar - HOPE FDA Program Update		18/09/24	1.71MB	Share
ZLD	AGM Date and Closing Date for Director Nominations		12/09/24	1.32MB	Share
ZLD	Appendix 4G		28/08/24	464.55KB	Share
ZLD	Appendix 4E and Financial Report to Shareholders	PRICE SENSITIVE	28/08/24	10.32MB	Share
ZLD	Zelira Receives Positive FDA Minutes from Pre-IND Meeting		22/08/24	1.71MB	Share
ZLD	Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/07/24	199.55KB	Share
ZLD	June 2024 Quarterly Activities Report	PRICE SENSITIVE	30/07/24	436.18KB	Share
ZLD	Zelira secures leading patents for HOPE 1 and HOPE 2		16/07/24	1023.43KB	Share
ZLD	ZLD Advances HOPE Autism Drug Program with U.S FDA Meeting	PRICE SENSITIVE	11/07/24	1.9MB	Share
ZLD	Zelira Receives USD$1.4Million Unsecured Loan from Chairman		04/07/24	317.84KB	Share
ZLD	ZLD secures US$1.4M unsecured Chairman loan facility	PRICE SENSITIVE	01/07/24	259.96KB	Share
ZLD	HOPE SPV receives US$681,000 third tranche of funding	PRICE SENSITIVE	23/05/24	1.36MB	Share
ZLD	Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/24	201.21KB	Share
ZLD	March 2024 Quarterly Activities Report	PRICE SENSITIVE	29/04/24	1.81MB	Share
ZLD	Zelira receives $919,000 R&D Tax Incentive Scheme Refund	PRICE SENSITIVE	15/04/24	1.49MB	Share
ZLD	Appendix 4D & FY24 Interim Financial Report	PRICE SENSITIVE	22/02/24	4.98MB	Share
ZLD	Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/24	393.48KB	Share
ZLD	December 2023 Quarterly Activities Report	PRICE SENSITIVE	31/01/24	1.49MB	Share
ZLD	Notification regarding unquoted securities - ZLD		29/01/24	34.84KB	Share
ZLD	Notification of cessation of securities - ZLD		23/01/24	21.61KB	Share
ZLD	Change of Auditor		11/01/24	1.44MB	Share
ZLD	HOPE SPV receives US$819,000 second tranche of funding	PRICE SENSITIVE	08/01/24	1.79MB	Share
ZLD	Change of Director's Interest Notice x 5		24/11/23	464.95KB	Share
ZLD	Notification regarding unquoted securities - ZLD		24/11/23	23.63KB	Share
ZLD	Proposed issue of securities - ZLD		23/11/23	46.95KB	Share
ZLD	Results of Meeting		15/11/23	498.66KB	Share
ZLD	2023 Annual General Meeting Presentation		15/11/23	17.64MB	Share
ZLD	Notification of cessation of securities - ZLD		13/11/23	21.52KB	Share
ZLD	Notification of cessation of securities - ZLD		03/11/23	21.59KB	Share
ZLD	Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/23	199KB	Share
ZLD	September 2023 Quarterly Activities Report	PRICE SENSITIVE	31/10/23	1.58MB	Share
ZLD	Letter to Shareholders		16/10/23	166.98KB	Share
ZLD	Notice of Annual General Meeting/Proxy Form		16/10/23	418.74KB	Share
ZLD	Appendix 4G and Corporate Governance Statement		29/09/23	479.87KB	Share
ZLD	Annual Report to shareholders		29/09/23	1.78MB	Share
ZLD	Change of registry address notification		15/09/23	265.68KB	Share
ZLD	AGM Date and Closing Date for Director Nominations		15/09/23	250.32KB	Share
ZLD	Change of Director's Interest Notice		11/09/23	208.77KB	Share
ZLD	Notification of cessation of securities - ZLD		11/09/23	25.36KB	Share
ZLD	Preliminary Final Report	PRICE SENSITIVE	31/08/23	349.94KB	Share
ZLD	Zelira closes $3.25M funding as part of HOPE SPV fundraise	PRICE SENSITIVE	17/08/23	3.32MB	Share
ZLD	Notification of cessation of securities - ZLD		14/08/23	21.73KB	Share
ZLD	Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/23	171.01KB	Share
ZLD	June 2023 Quarterly Activities Report	PRICE SENSITIVE	31/07/23	1.72MB	Share
ZLD	Amendment to ASX announcement - Zelira's diabetic nerve pai		08/06/23	1.71MB	Share
ZLD	Initial Director's Interest Notice		01/06/23	144.34KB	Share
ZLD	Final Director's Interest Notice		01/06/23	185.65KB	Share
ZLD	Proposed issue of securities - ZLD		31/05/23	27.27KB	Share
ZLD	Zelira Non-Executive Director Appointed		31/05/23	309.6KB	Share
ZLD	Top Line Results Investor Presentation		31/05/23	1.88MB	Share
ZLD	Investor Webinar - Top line trial results		31/05/23	1.38MB	Share
ZLD	Zeliras diabetic nerve pain drug outperforms Lyrica	PRICE SENSITIVE	31/05/23	401.78KB	Share
ZLD	Trading Halt	PRICE SENSITIVE	29/05/23	282.45KB	Share
ZLD	ZLD secures additional US$3.25M investment in HOPE SPV	PRICE SENSITIVE	22/05/23	577.78KB	Share
ZLD	Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/04/23	158.23KB	Share
ZLD	March 2023 Quarterly Activities Report	PRICE SENSITIVE	27/04/23	1.61MB	Share
ZLD	Section 708A Cleansing Notice		21/03/23	237.76KB	Share
ZLD	Application for quotation of securities - ZLD		21/03/23	24.73KB	Share
ZLD	Proposed issue of securities - ZLD		15/03/23	24.89KB	Share
ZLD	Zelira raises A$1.77 million from US-based investors	PRICE SENSITIVE	15/03/23	1.11MB	Share
ZLD	Trading Halt	PRICE SENSITIVE	13/03/23	610.74KB	Share
ZLD	Appendix 4D & FY23 Interim Financial Report	PRICE SENSITIVE	28/02/23	3.4MB	Share
ZLD	Zelira HOPE 1 SPV Investor Presentation		22/02/23	15.04MB	Share
ZLD	Initial Director's Interest Notice		21/02/23	147.24KB	Share
ZLD	Zelira HOPE 1 SPV Investor Briefing Webinar		21/02/23	434.03KB	Share
ZLD	Zelira Executive Director Appointed	PRICE SENSITIVE	20/02/23	505.42KB	Share
ZLD	Trading Halt	PRICE SENSITIVE	17/02/23	281.75KB	Share
ZLD	ZLD secures US$8.6 million funding for HOPE 1 US FDA trials	PRICE SENSITIVE	15/02/23	991.52KB	Share
ZLD	Trading Halt	PRICE SENSITIVE	13/02/23	282.11KB	Share
ZLD	Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/23	169.11KB	Share
ZLD	December 2022 Quarterly Activities Report	PRICE SENSITIVE	31/01/23	1.61MB	Share
ZLD	Zelira receives $1.14 million cash R&D Tax Incentive	PRICE SENSITIVE	30/01/23	1.09MB	Share

ZLD Preliminary Final Report
29/08/25	PRICE SENSITIVE	331.11KB	Share
ZLD Quarterly Activities/Appendix 4C Cash Flow Report
30/07/25	PRICE SENSITIVE	1.41MB	Share
ZLD Zelira Therapeutics Secures R&D Loan Facility
24/07/25	PRICE SENSITIVE	1.65MB	Share
ZLD Publication of ZLT-L-007 IRB Approved Observational Study
22/05/25	PRICE SENSITIVE	2.41MB	Share
ZLD Quarterly Activities/Appendix 4C Cash Flow Report
29/04/25	PRICE SENSITIVE	2.11MB	Share
ZLD Full Conversion of $USD3.25M Convertible Notes in HOPE SPV
28/04/25		1.66MB	Share
ZLD Investor Presentation
03/04/25		13.48MB	Share
ZLD Application for quotation of securities - ZLD
01/04/25		16.09KB	Share
ZLD Cleansing Prospectus
31/03/25		434.49KB	Share
ZLD Proposed issue of securities - ZLD
31/03/25		15.34KB	Share
ZLD Zelira secures $1 Million At-the-Market Funding Facility
31/03/25	PRICE SENSITIVE	1.94MB	Share
ZLD Appendix 4D & FY25 Interim Financial Report
26/02/25	PRICE SENSITIVE	3.46MB	Share
ZLD Zelira receives $1,153,000 R&D Tax Incentive Scheme Refund
18/02/25	PRICE SENSITIVE	1.36MB	Share
ZLD Quarterly Activities/Appendix 4C Cash Flow Report
30/01/25	PRICE SENSITIVE	1.83MB	Share
ZLD Zeliras HOPE SPV Secures US$681,000 Fourth Funding Tranche
28/01/25	PRICE SENSITIVE	1.54MB	Share
ZLD Change of Director's Interest Notice x 2
20/01/25		227.55KB	Share
ZLD Notification of cessation of securities - ZLD
17/01/25		12.76KB	Share
ZLD Change of Director's Interest Notice
19/12/24		208.86KB	Share
ZLD Notification regarding unquoted securities - ZLD
18/12/24		18.97KB	Share
ZLD Zelira to present at Automic Invest 2024 conference
20/11/24		267.35KB	Share
ZLD Proposed issue of securities - ZLD
14/11/24		18.41KB	Share
ZLD Results of Meeting
14/11/24		265.07KB	Share
ZLD 2024 Annual General Meeting Presentation
14/11/24		5.23MB	Share
ZLD Appendix 4C Cash Flow Report
29/10/24	PRICE SENSITIVE	205.83KB	Share
ZLD September 2024 Quarterly Activities Report
29/10/24	PRICE SENSITIVE	1.65MB	Share
ZLD Letter to Shareholders
11/10/24		222.62KB	Share
ZLD Notice of Annual General Meeting/Proxy Form
11/10/24		461.61KB	Share
ZLD Investor Webinar - HOPE FDA Program Update
20/09/24		1.29MB	Share
ZLD Notice of Investor Webinar - HOPE FDA Program Update
18/09/24		1.71MB	Share
ZLD AGM Date and Closing Date for Director Nominations
12/09/24		1.32MB	Share
ZLD Appendix 4G
28/08/24		464.55KB	Share
ZLD Appendix 4E and Financial Report to Shareholders
28/08/24	PRICE SENSITIVE	10.32MB	Share
ZLD Zelira Receives Positive FDA Minutes from Pre-IND Meeting
22/08/24		1.71MB	Share
ZLD Appendix 4C Cash Flow Report
30/07/24	PRICE SENSITIVE	199.55KB	Share
ZLD June 2024 Quarterly Activities Report
30/07/24	PRICE SENSITIVE	436.18KB	Share
ZLD Zelira secures leading patents for HOPE 1 and HOPE 2
16/07/24		1023.43KB	Share
ZLD ZLD Advances HOPE Autism Drug Program with U.S FDA Meeting
11/07/24	PRICE SENSITIVE	1.9MB	Share
ZLD Zelira Receives USD$1.4Million Unsecured Loan from Chairman
04/07/24		317.84KB	Share
ZLD ZLD secures US$1.4M unsecured Chairman loan facility
01/07/24	PRICE SENSITIVE	259.96KB	Share
ZLD HOPE SPV receives US$681,000 third tranche of funding
23/05/24	PRICE SENSITIVE	1.36MB	Share
ZLD Appendix 4C Cash Flow Report
29/04/24	PRICE SENSITIVE	201.21KB	Share
ZLD March 2024 Quarterly Activities Report
29/04/24	PRICE SENSITIVE	1.81MB	Share
ZLD Zelira receives $919,000 R&D Tax Incentive Scheme Refund
15/04/24	PRICE SENSITIVE	1.49MB	Share
ZLD Appendix 4D & FY24 Interim Financial Report
22/02/24	PRICE SENSITIVE	4.98MB	Share
ZLD Appendix 4C Cash Flow Report
31/01/24	PRICE SENSITIVE	393.48KB	Share
ZLD December 2023 Quarterly Activities Report
31/01/24	PRICE SENSITIVE	1.49MB	Share
ZLD Notification regarding unquoted securities - ZLD
29/01/24		34.84KB	Share
ZLD Notification of cessation of securities - ZLD
23/01/24		21.61KB	Share
ZLD Change of Auditor
11/01/24		1.44MB	Share
ZLD HOPE SPV receives US$819,000 second tranche of funding
08/01/24	PRICE SENSITIVE	1.79MB	Share
ZLD Change of Director's Interest Notice x 5
24/11/23		464.95KB	Share
ZLD Notification regarding unquoted securities - ZLD
24/11/23		23.63KB	Share
ZLD Proposed issue of securities - ZLD
23/11/23		46.95KB	Share
ZLD Results of Meeting
15/11/23		498.66KB	Share
ZLD 2023 Annual General Meeting Presentation
15/11/23		17.64MB	Share
ZLD Notification of cessation of securities - ZLD
13/11/23		21.52KB	Share
ZLD Notification of cessation of securities - ZLD
03/11/23		21.59KB	Share
ZLD Appendix 4C Cash Flow Report
31/10/23	PRICE SENSITIVE	199KB	Share
ZLD September 2023 Quarterly Activities Report
31/10/23	PRICE SENSITIVE	1.58MB	Share
ZLD Letter to Shareholders
16/10/23		166.98KB	Share
ZLD Notice of Annual General Meeting/Proxy Form
16/10/23		418.74KB	Share
ZLD Appendix 4G and Corporate Governance Statement
29/09/23		479.87KB	Share
ZLD Annual Report to shareholders
29/09/23		1.78MB	Share
ZLD Change of registry address notification
15/09/23		265.68KB	Share
ZLD AGM Date and Closing Date for Director Nominations
15/09/23		250.32KB	Share
ZLD Change of Director's Interest Notice
11/09/23		208.77KB	Share
ZLD Notification of cessation of securities - ZLD
11/09/23		25.36KB	Share
ZLD Preliminary Final Report
31/08/23	PRICE SENSITIVE	349.94KB	Share
ZLD Zelira closes $3.25M funding as part of HOPE SPV fundraise
17/08/23	PRICE SENSITIVE	3.32MB	Share
ZLD Notification of cessation of securities - ZLD
14/08/23		21.73KB	Share
ZLD Appendix 4C Cash Flow Report
31/07/23	PRICE SENSITIVE	171.01KB	Share
ZLD June 2023 Quarterly Activities Report
31/07/23	PRICE SENSITIVE	1.72MB	Share
ZLD Amendment to ASX announcement - Zelira's diabetic nerve pai
08/06/23		1.71MB	Share
ZLD Initial Director's Interest Notice
01/06/23		144.34KB	Share
ZLD Final Director's Interest Notice
01/06/23		185.65KB	Share
ZLD Proposed issue of securities - ZLD
31/05/23		27.27KB	Share
ZLD Zelira Non-Executive Director Appointed
31/05/23		309.6KB	Share
ZLD Top Line Results Investor Presentation
31/05/23		1.88MB	Share
ZLD Investor Webinar - Top line trial results
31/05/23		1.38MB	Share
ZLD Zeliras diabetic nerve pain drug outperforms Lyrica
31/05/23	PRICE SENSITIVE	401.78KB	Share
ZLD Trading Halt
29/05/23	PRICE SENSITIVE	282.45KB	Share
ZLD ZLD secures additional US$3.25M investment in HOPE SPV
22/05/23	PRICE SENSITIVE	577.78KB	Share
ZLD Appendix 4C Cash Flow Report
27/04/23	PRICE SENSITIVE	158.23KB	Share
ZLD March 2023 Quarterly Activities Report
27/04/23	PRICE SENSITIVE	1.61MB	Share
ZLD Section 708A Cleansing Notice
21/03/23		237.76KB	Share
ZLD Application for quotation of securities - ZLD
21/03/23		24.73KB	Share
ZLD Proposed issue of securities - ZLD
15/03/23		24.89KB	Share
ZLD Zelira raises A$1.77 million from US-based investors
15/03/23	PRICE SENSITIVE	1.11MB	Share
ZLD Trading Halt
13/03/23	PRICE SENSITIVE	610.74KB	Share
ZLD Appendix 4D & FY23 Interim Financial Report
28/02/23	PRICE SENSITIVE	3.4MB	Share
ZLD Zelira HOPE 1 SPV Investor Presentation
22/02/23		15.04MB	Share
ZLD Initial Director's Interest Notice
21/02/23		147.24KB	Share
ZLD Zelira HOPE 1 SPV Investor Briefing Webinar
21/02/23		434.03KB	Share
ZLD Zelira Executive Director Appointed
20/02/23	PRICE SENSITIVE	505.42KB	Share
ZLD Trading Halt
17/02/23	PRICE SENSITIVE	281.75KB	Share
ZLD ZLD secures US$8.6 million funding for HOPE 1 US FDA trials
15/02/23	PRICE SENSITIVE	991.52KB	Share
ZLD Trading Halt
13/02/23	PRICE SENSITIVE	282.11KB	Share
ZLD Appendix 4C Cash Flow Report
31/01/23	PRICE SENSITIVE	169.11KB	Share
ZLD December 2022 Quarterly Activities Report
31/01/23	PRICE SENSITIVE	1.61MB	Share
ZLD Zelira receives $1.14 million cash R&D Tax Incentive
30/01/23	PRICE SENSITIVE	1.09MB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 38.0¢		Change -0.030(7.32%)		Mkt cap ! $4.877M

Open	High	Low	Value	Volume
40.0¢	40.0¢	38.0¢	$1.156K	2.971K

Buyers (Bids)

No.	Vol.	Price($)
2	5701	38.0¢

Sellers (Offers)

Price($)	Vol.	No.
40.0¢	847	2

View Market Depth

No.	Vol.	Price($)
2	5702	0.380
2	6190	0.375
1	8110	0.370
1	5479	0.365
1	2780	0.360

Price($)	Vol.	No.
0.400	847	2
0.420	6158	1
0.440	87	1
0.450	246	2
0.470	2629	2

Last trade - 10.20am 15/09/2025 (20 minute delay)

ZLD (ASX) Chart

ZELIRA THERAPEUTICS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories